a strong trendp <0.15
On the target gene protein expression level, STAT3-MB + UTMC-treated tumors exhibited a strong trend towards decreased expression of Bcl-xL (normalized by GAPDH) (36.9±25.7%) compared to the mutant control (94.5±50.1%, p <0.15).